Between family variation in EPA and DHA storage among Atlantic salmon (Salmo salar) fed a fish oil-free diet

Abstract

Biosynthesis and storage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is under dietary and genetic control in Atlantic salmon (Salmo salar). Enhanced EPA and DHA biosynthesis and storage may improve utilization, and thus reduce marine forage fish oil use in aquafeeds. To determine phenotypic variability in EPA and DHA tissue content and growth performance, 50 families (n = 30 salmon/family, 48 g/fish initial weight) of Atlantic salmon (Saint John River strain) were reared in freshwater and fed either a fish oil (FO) control diet or FO-free diet. After 16 weeks, body size was recorded. Salmon fed the FO-free diet overall showed significantly lower growth performance compared to salmon fed the FO control diet, regardless of family. To determine the relationship between growth and FA content, the five families with the highest and the five families with the lowest weight gain were sampled for tissue and liver FA analysis. There was a significant interaction between growth and diet. The family x diet interaction was significant for final weight, final length, weight gain, growth rate and feed conversion ratio. Among the five fastest growing families, there was a significant family effect for EPA and DHA storage in the liver but not for muscle. Among the five slowest growing families, by comparison salmon had similar liver DHA and EPA content, independent of diet treatment. Family and diet were interacting factors that determine EPA and DHA storage in liver. Certain fast-growing families also had significantly higher DHA content in liver and muscle. This study demonstrates the potential for selecting families that can better utilize a diet without marine forage fish oil.